| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.35B | 29.11B | 17.35B | 20.39B | 18.27B | 20.75B |
| Gross Profit | 14.81B | 24.73B | 12.94B | 19.52B | 17.48B | 19.98B |
| EBITDA | 17.53B | 22.78B | 22.15B | 20.87B | 12.29B | 16.34B |
| Net Income | 12.30B | 17.72B | 13.05B | 11.86B | 10.08B | 12.54B |
Balance Sheet | ||||||
| Total Assets | 424.87B | 580.72B | 381.63B | 341.18B | 406.05B | 399.30B |
| Cash, Cash Equivalents and Short-Term Investments | 282.46B | 318.22B | 230.91B | 203.98B | 276.39B | 342.33B |
| Total Debt | 873.00M | 1.25B | 1.68B | 2.05B | 2.24B | 2.06B |
| Total Liabilities | 367.42B | 522.00B | 327.22B | 289.38B | 355.95B | 349.39B |
| Stockholders Equity | 56.91B | 58.14B | 53.85B | 51.34B | 49.73B | 49.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 20.93B | 11.17B | 10.11B | 13.67B | 11.27B |
| Operating Cash Flow | 0.00 | 22.66B | 12.77B | 11.50B | 14.96B | 12.34B |
| Investing Cash Flow | 0.00 | -7.73B | 3.19B | -6.29B | -1.70B | 2.28B |
| Financing Cash Flow | 0.00 | -14.56B | -11.26B | -11.25B | -10.37B | -12.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | $108.60B | 24.28 | 14.48% | 3.92% | 5.84% | 8.51% | |
80 Outperform | $31.08B | 23.89 | 22.99% | 1.06% | 16.74% | 26.74% | |
72 Outperform | $66.62B | 28.93 | 32.11% | 2.52% | 35.69% | 30.09% | |
72 Outperform | $95.29B | 28.00 | 11.60% | 1.19% | 8.96% | 30.16% | |
71 Outperform | $79.36B | 37.25 | 62.81% | 0.73% | 8.77% | 13.62% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $50.07B | 26.70 | 15.03% | 1.07% | 16.41% | 68.03% |